| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |